Somavert



Indications and Reactions:

Role Indications Reactions
Primary
Acromegaly 60.6%
Hypertension 10.8%
Pituitary Tumour 3.3%
Depression 2.8%
Diabetes Mellitus 2.8%
Gigantism 2.8%
Hypopituitarism 1.9%
Hypothyroidism 1.9%
Gastrooesophageal Reflux Disease 1.4%
Hypothalamo-pituitary Disorder 1.4%
Type 2 Diabetes Mellitus 1.4%
Insulin-like Growth Factor Increased 1.3%
Pituitary Tumour Benign 1.3%
Blood Pressure Abnormal 1.1%
Blood Thyroid Stimulating Hormone Decreased 1.1%
Ill-defined Disorder 0.9%
Blood Cholesterol Increased 0.8%
Blood Growth Hormone Increased 0.8%
Lipids Abnormal 0.8%
Blood Corticotrophin Decreased 0.6%
Death 13.7%
Pituitary Tumour Benign 8.1%
Weight Increased 8.1%
Drug Ineffective 6.2%
Insulin-like Growth Factor Increased 5.6%
Hepatic Enzyme Increased 5.0%
Pituitary Tumour Recurrent 5.0%
Headache 4.3%
Injection Site Pain 4.3%
Nausea 4.3%
Depression 3.7%
Fatigue 3.7%
Hepatitis 3.7%
Hypersensitivity 3.7%
Lipodystrophy Acquired 3.7%
Rash 3.7%
Vomiting 3.7%
Abdominal Distension 3.1%
Diarrhoea 3.1%
Injection Site Reaction 3.1%
Secondary
Acromegaly 55.3%
Gigantism 10.6%
Pituitary Tumour 5.7%
Pituitary Tumour Benign 4.1%
Blood Pressure Abnormal 2.8%
Abnormal Behaviour 2.4%
Hypertension 2.0%
Hypothalamo-pituitary Disorder 2.0%
Insulin-like Growth Factor Increased 2.0%
Gastrooesophageal Reflux Disease 1.6%
Osteoporosis Prophylaxis 1.6%
Benign Neoplasm 1.2%
Blood Growth Hormone Abnormal 1.2%
Blood Growth Hormone Increased 1.2%
Hypothyroidism 1.2%
Product Used For Unknown Indication 1.2%
Rickets 1.2%
Adrenal Insufficiency 0.8%
Depression 0.8%
Diabetes Mellitus 0.8%
Pituitary Tumour Benign 11.1%
Weight Increased 8.6%
Insulin-like Growth Factor Increased 7.4%
Pulmonary Embolism 6.2%
Thyroid Disorder 6.2%
Fatigue 4.9%
Injection Site Pain 4.9%
Nausea 4.9%
Off Label Use 4.9%
Tremor 4.9%
Abdominal Pain 3.7%
Drug Ineffective 3.7%
General Physical Health Deterioration 3.7%
Headache 3.7%
Inflammation 3.7%
Injection Site Bruising 3.7%
Pituitary Tumour 3.7%
Pituitary Tumour Removal 3.7%
Vitamin D Deficiency 3.7%
Abdominal Distension 2.5%
Concomitant
Acromegaly 46.3%
Product Used For Unknown Indication 22.4%
Pituitary Tumour 7.5%
Hypertension 4.5%
Pituitary Tumour Benign 4.5%
Hypopituitarism 3.0%
Hypothalamo-pituitary Disorder 3.0%
Carcinoid Syndrome 1.5%
Cushing's Syndrome 1.5%
Depression 1.5%
Oesophagitis 1.5%
Off Label Use 1.5%
Type 2 Diabetes Mellitus 1.5%
Glycosylated Haemoglobin Increased 11.1%
Cerebrovascular Accident 7.4%
Death 7.4%
Diverticulum 7.4%
Injection Site Abscess 7.4%
Nervous System Disorder 7.4%
Blood Glucose Decreased 3.7%
Chemical Peritonitis 3.7%
Disorientation 3.7%
Drug Ineffective 3.7%
Haemangioma Of Liver 3.7%
Hip Fracture 3.7%
Hospitalisation 3.7%
Injection Site Haematoma 3.7%
Lung Neoplasm Malignant 3.7%
Mass 3.7%
Mixed Liver Injury 3.7%
Muscle Twitching 3.7%
Nausea 3.7%
Needle Issue 3.7%